Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001081817 | SCV000290495 | likely benign | Developmental and epileptic encephalopathy, 14; Autosomal dominant nocturnal frontal lobe epilepsy 5 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000425920 | SCV000511466 | uncertain significance | not provided | 2016-07-11 | criteria provided, single submitter | clinical testing | Converted during submission to Uncertain significance. |
Gene |
RCV000444916 | SCV000523702 | likely benign | not specified | 2017-10-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV002313959 | SCV000848806 | likely benign | Inborn genetic diseases | 2019-01-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000425920 | SCV000856258 | uncertain significance | not provided | 2017-08-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000425920 | SCV004010893 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | KCNT1: BP4, BS1 |
ARUP Laboratories, |
RCV000425920 | SCV004562105 | likely benign | not provided | 2023-09-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003939883 | SCV004759281 | likely benign | KCNT1-related condition | 2020-02-03 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |